Associations of Aspirin and NSAIDs and CRC Mortality Associations of Aspirin and NSAIDs and CRC Mortality
What are the potential benefits and harms of aspirin and NSAID use on colorectal cancer mortality outcomes?Journal of the National Cancer Institute (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 29, 2021 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Meet the Patients Who Helped Run a Big Aspirin Trial Meet the Patients Who Helped Run a Big Aspirin Trial
WebMD Health News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - July 23, 2021 Category: Cardiology Tags: Cardiology News Source Type: news

P2Y12 Inhibitors+Aspirin vs. Aspirin Alone in Minor Stroke P2Y12 Inhibitors+Aspirin vs. Aspirin Alone in Minor Stroke
This review compared the effectiveness and safety of DAPT therapy with P2Y12 inhibitors and aspirin versus aspirin monotherapy in patients with mild ischemic stroke or high-risk TIA.Stroke (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - July 22, 2021 Category: Intensive Care Tags: Neurology & Neurosurgery Journal Article Source Type: news

Is Aspirin Overused in Older Patients With Diabetes? Is Aspirin Overused in Older Patients With Diabetes?
A study of trends in aspirin use in older US adults finds those with diabetes are twice as likely to use aspirin for primary prevention as those without diabetes; many patients might now need review.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - July 16, 2021 Category: Cardiology Tags: Diabetes & Endocrinology News Source Type: news

Ticagrelor Beneficial for Moderate Stroke: New THALES Analysis Ticagrelor Beneficial for Moderate Stroke: New THALES Analysis
For patients with a moderate-size stroke, the benefit from ticagrelor plus aspirin is the same as for patients with minor stroke, a new exploratory analysis of the THALES trial shows.Medscape Medical News (Source: Medscape Emergency Medicine Headlines)
Source: Medscape Emergency Medicine Headlines - July 16, 2021 Category: Emergency Medicine Tags: Neurology & Neurosurgery News Source Type: news

Low - Dose Aspirin Cuts Heart Risks in Patients Battling Pneumonia
(Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - July 8, 2021 Category: Respiratory Medicine Tags: Cardiology, Family Medicine, Neurology, Pulmonology, News, Source Type: news

Low-Dose Aspirin Cuts Heart Risks in Patients Battling Pneumonia
THURSDAY, July 8, 2021 -- Aspirin has long been taken by heart patients to reduce the risk of stroke and heart attack, but a new study suggests that it can also guard against cardiovascular trouble in pneumonia patients. Such complications are... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 8, 2021 Category: General Medicine Source Type: news

Low-Dose Aspirin Cuts Heart Risks in Patients Battling Pneumonia
Title: Low-Dose Aspirin Cuts Heart Risks in Patients Battling PneumoniaCategory: Health NewsCreated: 7/8/2021 12:00:00 AMLast Editorial Review: 7/8/2021 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - July 8, 2021 Category: Cardiology Source Type: news

Study shows aspirin can reduce the risk of heart attacks and strokes in patients with pneumonia
Aspirin can reduce the risk of serious cardiovascular events such as ischemic stroke and heart attack in patients with pneumonia, according to new research. (Source: University of Bristol news)
Source: University of Bristol news - July 7, 2021 Category: Universities & Medical Training Tags: Research; Faculty of Health Sciences, Faculty of Health Sciences, Bristol Medical School; Press Release Source Type: news

DAPT vs. Aspirin in Patients With Stroke or TIA DAPT vs. Aspirin in Patients With Stroke or TIA
This study found that compared with aspirin alone, DAPT given within 24 hours of high-risk TIA or mild to moderate stroke reduces the risk of recurrent stroke, but comes with higher risk of bleeding.Stroke (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 5, 2021 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news

Taking aspirin can slash your chance of dying from cancer by a fifth
ASTONISHING research uncovered the potential life-saving capabilities of aspirin. Professor Peter Elwood and his team from Cardiff University found that the painkiller dramatically "cut the risk of death" in cancer patients. (Source: Daily Express - Health)
Source: Daily Express - Health - July 4, 2021 Category: Consumer Health News Source Type: news

FDA Drug Safety Communication: FDA strengthens warning that non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) can cause heart attacks or strokes
[FDA strengthens warning that non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) can cause heart attacks or strokes (FDA Drug Safety Communication). Based on FDA ’s comprehensive review of new safety information, the agency is requiring updates to the drug labels of all prescription NSAIDs. Widely used to treat pain and fever from many different long- and short-term medical conditions such as arthritis, menstrual cramps, headaches, colds, and the flu, NSAI Ds are available by prescription and OTC. Examples of NSAIDs include ibuprofen, naproxen, diclofenac, and celecoxib. (Source: FDA Center for Drug Evaluation...
Source: FDA Center for Drug Evaluation and Research - What's New - June 29, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Why you might be able to stay on HRT for the rest of your life, writes DR PHILIPPA KAYE
DR PHILIPPA KAYE: Recently I've written about potential downsides of staying on some common medications for too long - such as aspirin, certain acid reflux drugs and even antidepressants. (Source: the Mail online | Health)
Source: the Mail online | Health - June 26, 2021 Category: Consumer Health News Source Type: news

Janssen Submits New Drug Application to U.S. FDA for XARELTO ® (rivaroxaban) to Help Prevent and Treat Blood Clots in Pediatric Patients
RARITAN, NJ, June 23, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the use of XARELTO® (rivaroxaban) in pediatric patients. The NDA seeks two pediatric indications: treatment of venous thromboembolism (VTE, or blood clots) and reduction in the risk of recurrent VTE in patients aged birth to less than 18 years of age after at least five days of initial parenteral anticoagulant treatment; and thromboprophylaxis (prevention of blood clots) in patients aged 2 years and older with co...
Source: Johnson and Johnson - June 23, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Too Many Older Americans Are Taking Daily Aspirin
Title: Too Many Older Americans Are Taking Daily AspirinCategory: Health NewsCreated: 6/22/2021 12:00:00 AMLast Editorial Review: 6/23/2021 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - June 23, 2021 Category: Cardiology Source Type: news

Too Many Older Americans Are Taking Daily Aspirin
TUESDAY, June 22, 2021 -- Many older adults are still taking a daily baby aspirin to ward off first-time heart problems— despite guidelines that now discourage it, a new study finds. Researchers found that one-half to 62% of U.S. adults aged... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 22, 2021 Category: General Medicine Source Type: news

Preventive Aspirin Use Up for Seniors With Versus Without Diabetes
TUESDAY, June 22, 2021 -- Aspirin use for primary prevention of cardiovascular disease (CVD) is higher for older adults with diabetes versus those without diabetes, according to a study published online June 21 in JAMA Network Open. Elizabeth Y.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 22, 2021 Category: Pharmaceuticals Source Type: news

Study: 10M people in U.S. improperly use daily aspirin therapy
Nearly 10 million older adults in the United States who take aspirin daily to prevent heart attacks shouldn't be using the drug, according to an analysis published Monday by JAMA Network Open. (Source: Health News - UPI.com)
Source: Health News - UPI.com - June 21, 2021 Category: Consumer Health News Source Type: news

DR PHILIPPA KAYE: Why it might be time to ease off your daily aspirin
DR PHILIPPA KAYE: More than one million Britons, roughly 40 per cent of over-60s, are prescribed a daily dose of aspirin to help prevent heart attacks and strokes in those who have already had one. (Source: the Mail online | Health)
Source: the Mail online | Health - June 19, 2021 Category: Consumer Health News Source Type: news

RECOVERY trial finds aspirin does not improve survival for patients hospitalised with COVID-19, Recovery Trial
In the study (n=14,892), there was no evidence that aspirin 150 mg daily reduced mortality vs usual care (28 day mortality of 17% for both arms). The results were consistent across all pre-specified subgroups of patients. 8 June. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 17, 2021 Category: Consumer Health News Source Type: news

ACC 2021 Highlights: Drugs and Alcohol ACC 2021 Highlights: Drugs and Alcohol
Aspirin dosing, alcohol and atrial fibrillation, dual vs mono antiplatelet therapy post PCI, and sacubitril/valsartan post MI are among the drug highlights from ACC 2021.theheart.org on Medscape (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 15, 2021 Category: Consumer Health News Tags: Cardiology News Source Type: news

Aspirin Does Not Improve Survival in COVID-19 Patients: UK Study Aspirin Does Not Improve Survival in COVID-19 Patients: UK Study
Aspirin does not improve the chances of survival in severely ill COVID-19 patients, early results from one of Britain's biggest trials studying the commonly used painkiller and blood thinner showed on Tuesday.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - June 9, 2021 Category: Intensive Care Tags: Infectious Diseases News Source Type: news

RECOVERY trial finds aspirin does not improve survival for patients hospitalised with COVID-19, University of Oxford
The RECOVERY trial was established as a randomised clinical trial to test a range of potential treatments for patients hospitalised with COVID-19. Patients with COVID-19 are at increased risk of blood clots forming in their blood vessels, particularly in the lungs. Between November 2020 and March 2021, the RECOVERY trial included nearly 15,000 patients hospitalised with COVID-19 in an assessment of the effects of aspirin, which is widely used to reduce blood clotting in other diseases. A total of 7351 patients were randomised to aspirin 150 mg once daily and compared with 7541 patients randomised to usual care alon...
Source: Current Awareness Service for Health (CASH) - June 8, 2021 Category: Consumer Health News Source Type: news

Coronavirus: Aspirin does not improve survival odds for Covid hospital patients, study finds
The RECOVERY trial, run by the University of Oxford in NHS hospitals across the UK, tested aspirin on more than 7,000 patients with Covid and did not find that they were more likely to survive than others. (Source: the Mail online | Health)
Source: the Mail online | Health - June 8, 2021 Category: Consumer Health News Source Type: news

Early Aspirin Withdrawal After PCI: More Benefit for Women? Early Aspirin Withdrawal After PCI: More Benefit for Women?
A new analysis from the TWILIGHT trial shows some interesting observations on the effects of ticagrelor monotherapy vs dual antiplatelet therapy in women and men.Medscape Medical News (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - May 20, 2021 Category: Primary Care Tags: Cardiology News Source Type: news

Low- or High-Dose, Aspirin Brings Similar Protection Against Heart Disease: Study
TUESDAY, May 18, 2021 -- When it comes to taking a daily aspirin to cut heart patients'risk of heart attack and stroke, a new study finds dosing doesn't matter. Researchers looked at more than 15,000 heart disease patients at 40 health centers... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 18, 2021 Category: General Medicine Source Type: news

Low- or High-Dose, Aspirin Brings Similar Protection Against Heart Disease: Study
Title: Low- or High-Dose, Aspirin Brings Similar Protection Against Heart Disease: StudyCategory: Health NewsCreated: 5/18/2021 12:00:00 AMLast Editorial Review: 5/18/2021 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - May 18, 2021 Category: Cardiology Source Type: news

HOST-EXAM: Clopidogrel Beats Aspirin as Monotherapy After Stenting HOST-EXAM: Clopidogrel Beats Aspirin as Monotherapy After Stenting
For patients who had completed a period of dual antiplatelet therapy, clopidogrel alone was linked to lower rates of both ischemic events and bleeding compared to aspirin.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - May 17, 2021 Category: Neurology Tags: Cardiology News Source Type: news

Does ADAPTABLE Inform Aspirin Dosing for Secondary Prevention? Does ADAPTABLE Inform Aspirin Dosing for Secondary Prevention?
Patient engagement, social media, and the internet all contributed to the unique design of the ADAPTABLE trial, but did it answer the question on the best dose of aspirin to use?theheart.org on Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 17, 2021 Category: Consumer Health News Tags: Cardiology Commentary Source Type: news

ACC: 81-mg, 325-mg Aspirin Similarly Effective in ASCVD
MONDAY, May 17, 2021 -- For patients with established atherosclerotic cardiovascular disease, there is no significant difference in cardiovascular events or major bleeding for those receiving 81 mg or 325 mg of aspirin daily, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 17, 2021 Category: Pharmaceuticals Source Type: news

Aspirin May Help Protect the Brain From Pollution's Toll, Study Suggests
Even short-term exposure to polluted air may impair mental ability in the elderly. Aspirin and other NSAIDs showed some protective effects. (Source: NYT Health)
Source: NYT Health - May 17, 2021 Category: Consumer Health News Authors: Nicholas Bakalar Tags: Air Pollution Nonsteroidal Anti-inflammatory Drugs (NSAIDs) Aspirin Elderly Dementia Alzheimer ' s Disease Brain Source Type: news

Late-Breaking Data at ACC.21 Show XARELTO ® (rivaroxaban) Plus Aspirin Significantly Reduced Total Ischemic Events in Peripheral Artery Disease (PAD) Patients After Lower-Extremity Revascularization
RARITAN, N.J., May 16, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today presented new data from the Phase 3 VOYAGER PAD study which showed XARELTO® (rivaroxaban) (2.5 mg twice daily) in combination with aspirin (100 mg once daily) consistently reduced severe vascular events in patients with peripheral artery disease (PAD) after lower-extremity revascularization (LER) compared to aspirin alone regardless of whether it was the first, second, third, or subsequent event. The primary results of VOYAGER PAD showed that XARELTO® plus aspirin reduced first events by 15 percent among patients...
Source: Johnson and Johnson - May 16, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Heart study: Low- and regular-dose aspirin safe, effective
A large study finds that low-dose and regular-strength aspirin seem equally safe and effective for preventing additional heart problems in people who already have heart disease (Source: ABC News: Health)
Source: ABC News: Health - May 15, 2021 Category: Consumer Health News Tags: Health Source Type: news

ADAPTABLE: Low-Dose Aspirin as Good as High-Dose in CHD? ADAPTABLE: Low-Dose Aspirin as Good as High-Dose in CHD?
A large randomized trial specifically designed to investigate the optimum dose of aspirin in patients with established coronary disease has found similar efficacy and safety with 81 mg and 325 mg.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - May 15, 2021 Category: Cardiology Tags: Cardiology News Source Type: news

Fiorinal with Codeine (butalbital, aspirin, caffeine, and codeine phosphate)
Title: Fiorinal with Codeine (butalbital, aspirin, caffeine, and codeine phosphate)Category: MedicationsCreated: 5/14/2021 12:00:00 AMLast Editorial Review: 5/14/2021 12:00:00 AM (Source: MedicineNet Migraine General)
Source: MedicineNet Migraine General - May 14, 2021 Category: Neurology Source Type: news

Mandrola Previews (Virtual) ACC 2021 Mandrola Previews (Virtual) ACC 2021
Presentations on aspirin dosing, surgical left atrial appendage occlusion, heart failure rehab, and rate vs rhythm control are among the top picks from the virtual ACC 2021, according to John Mandrola, MD.theheart.org on Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - May 10, 2021 Category: Cardiology Tags: Cardiology Expert Column Source Type: news

Percodan (aspirin and oxycodone hydrochloride)
Title: Percodan (aspirin and oxycodone hydrochloride)Category: MedicationsCreated: 5/7/2021 12:00:00 AMLast Editorial Review: 5/7/2021 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - May 7, 2021 Category: Drugs & Pharmacology Source Type: news

Norgesic (orphenadrine citrate, aspirin and caffeine)
Title: Norgesic (orphenadrine citrate, aspirin and caffeine)Category: MedicationsCreated: 5/7/2021 12:00:00 AMLast Editorial Review: 5/7/2021 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - May 7, 2021 Category: Drugs & Pharmacology Source Type: news

Adding Aspirin May Up Risk for Patients on DOAC for A - Fib/VTE
Among patients with a - fib and/or VTE, about one - third received ASA in addition to a DOAC with no clear indication for ASA (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - May 4, 2021 Category: Cancer & Oncology Tags: Cardiology, Family Medicine, Internal Medicine, Oncology, Pharmacy, Journal, Source Type: news

Adding Aspirin May Up Risk for Patients on DOAC for A-Fib/VTE
TUESDAY, May 4, 2021 -- About one-third of patients with atrial fibrillation (AF) and/or venous thromboembolic disease (VTE) receive acetylsalicylic acid (ASA) in addition to a direct oral anticoagulant (DOAC) without a clear indication, according... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 4, 2021 Category: Pharmaceuticals Source Type: news

Even short-term exposure to air pollution could affect cognition, shows study
According to a new study at Columbia University, being exposed to air pollution can affect one's mind. Even if the exposure lasts for a few weeks, the effects of the pollution can be mitigated with nonsteroidal anti-inflammatory drugs like aspirin. (Source: The Economic Times)
Source: The Economic Times - May 4, 2021 Category: Consumer Health News Source Type: news

Short-term exposure to air pollution may impede cognition; Aspirin could help
(Columbia University's Mailman School of Public Health) Exposure to air pollution, even over the course of just a few weeks, can impede mental performance, according to a new study led by researchers at Columbia University Mailman School of Public Health. However, these adverse effects were lessened in people taking nonsteroidal anti-inflammatory drugs (NSAIDs) like aspirin. The study is among the first to explore short-term air pollution exposures and the use of NSAIDs to mitigate their effects. The results are published in the journal Nature Aging. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 3, 2021 Category: International Medicine & Public Health Source Type: news

Does the AstraZeneca vaccine cause more common side-effects than others? Your Coronavirus questions answered
Also: Can I mix vaccine brands yet? And does taking Aspirin reduce the risk of getting a blood clot? More answers to your pandemic questions. (Source: CBC | Health)
Source: CBC | Health - April 28, 2021 Category: Consumer Health News Tags: News/Health Source Type: news

Two Is Not Better Than One When It Comes to Blood Thinners
THURSDAY, April 22, 2021 -- It may not be a good idea to take a daily low-dose aspirin if you're also taking a widely used class of blood thinners called direct oral anticoagulants (DOACs), researchers caution. DOACs include drugs such as Eliquis... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 22, 2021 Category: General Medicine Source Type: news

Many AFib patients wrongly prescribed aspirin therapy, study finds
More than one-third of people who have atrial fibrillation or blood clots are treated with both a blood-thinner and daily aspirin therapy, even when there is no clear need for the latter, a JAMA study found. (Source: Health News - UPI.com)
Source: Health News - UPI.com - April 19, 2021 Category: Consumer Health News Source Type: news

Two blood thinners at once: More risk with the same reward
(Michigan Medicine - University of Michigan) For some patients, adding aspirin to a direct oral anticoagulant is an equation that rarely adds up. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 19, 2021 Category: International Medicine & Public Health Source Type: news

Biosimilars outlook and why they could be a boon to a strained U.S. health care system
The history of generic drugs can be traced to the 1920s when the manufacturer of aspirin went to court to keep generic versions off store and pharmacy shelves. The company lost when the court learned “aspirin” had become the generic name for the product. This case and decades of legislative accomplishments since have paved the way for a thriving generics drug industry, which now accounts for 90% of prescriptions filled in the U.S. Generics have made more medicines accessible to more patients ,… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - April 8, 2021 Category: American Health Authors: Laura Newpoff Source Type: news

Aspirin in COVID-19-Related Acute Respiratory Distress Syndrome Aspirin in COVID-19-Related Acute Respiratory Distress Syndrome
A new study found aspirin use independently associated with a reduced risk of mechanical ventilation in COVID-19 patients. What might be the pathophysiological rationale behind aspirin's efficacy?Anesthesia & Analgesia (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 5, 2021 Category: Consumer Health News Tags: Anesthesiology Journal Article Source Type: news

Dr Chris on why he has taken 'low-dose' aspirin daily for years
DR CHRIS divulged his daily devotion to pop a "low-dose" aspirin into his mouth. Why is the anti-inflammatory painkiller part of his healthcare routine? Find out here. (Source: Daily Express - Health)
Source: Daily Express - Health - April 1, 2021 Category: Consumer Health News Source Type: news

Dr Chris highlights 'remarkable' aspirin as it reduces risk of 'dying' from Covid
DR CHRIS - the resident doctor for This Morning - highlighted the "remarkable" benefit of taking aspirin. The everyday painkiller is said to reduce the risk of dying from Covid. (Source: Daily Express - Health)
Source: Daily Express - Health - April 1, 2021 Category: Consumer Health News Source Type: news